Hemostatic abnormalities in inflammatory bowel disease

Patients affected by inflammatory bowel disease (IBD) frequently suffer from thromboembolic events. Aims of this study were to investigate hemostatic system and the presence of antiphospholipid antibodies (aPL) in IBD patients. Forty-one patients affected by Crohn's disease (CD) and 19 by ulcer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 1996-04, Vol.82 (2), p.137-146
Hauptverfasser: Chiarantini, Elena, Valanzano, Rosa, Liotta, Agatina Alessandrello, Cellai, Anna Paola, Fedi, Sandra, Ilari, Isabella, Prisco, Demenico, Tonelli, Francesco, Abbate, Rosanna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146
container_issue 2
container_start_page 137
container_title Thrombosis research
container_volume 82
creator Chiarantini, Elena
Valanzano, Rosa
Liotta, Agatina Alessandrello
Cellai, Anna Paola
Fedi, Sandra
Ilari, Isabella
Prisco, Demenico
Tonelli, Francesco
Abbate, Rosanna
description Patients affected by inflammatory bowel disease (IBD) frequently suffer from thromboembolic events. Aims of this study were to investigate hemostatic system and the presence of antiphospholipid antibodies (aPL) in IBD patients. Forty-one patients affected by Crohn's disease (CD) and 19 by ulcerative colitis (UC) were studied, compared to 40 healthy control subjects. platelet count (PLT), PT, aPTT, fibrinogen (Fib), prothrombin fragment F1+2, antithrombin (AT), protein C (PC), protein S (PS), factor XIII (FXIII), plasminogen (PLG), plasminogen activator inhibitor (PAI), spontaneous platelet aggregation in platelet-rich plasma (PRP-SPA) and in whole blood (WB-SPA), and antiphospholipid antibodies (aPL) were evaluated. PLT, Fib, F1+2 and WB-SPA were significantly increased in IBD patients (p at least
doi_str_mv 10.1016/0049-3848(96)00060-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78431838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0049384896000606</els_id><sourcerecordid>78431838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-845bb621bfa03fd681224ed2caae73ff87f9886831545f20ae19f1400e70ed8d3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo67r6DxR6ENFDdZKmaXIRZFFXWPCi55CmE4j0Y026yv57W7bsURgYhveZYXgIuaRwT4GKBwCu0kxyeavEHQAISMURmVNZqJTxgh2T-QE5JWcxfgHQgqp8RmaKigxEMSdihU0Xe9N7m5iy7UJjat97jIlvh3K1aRrTd2GXlN0v1knlI5qI5-TEmTrixdQX5PPl-WO5Stfvr2_Lp3Vqec76VPK8LAWjpTOQuUpIyhjHilljsMick4VTUgqZ0ZznjoFBqhzlAFgAVrLKFuRmf3cTuu8txl43Plqsa9Nit426kDyjMpMDyPegDV2MAZ3eBN-YsNMU9KhLjy706EKrcRh0aTGsXU33t2WD1WFp8jPk11NuojW1C6a1Ph6wgeGK8QF73GM4uPjxGHS0HluLlQ9oe111_v8__gBj94WR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78431838</pqid></control><display><type>article</type><title>Hemostatic abnormalities in inflammatory bowel disease</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chiarantini, Elena ; Valanzano, Rosa ; Liotta, Agatina Alessandrello ; Cellai, Anna Paola ; Fedi, Sandra ; Ilari, Isabella ; Prisco, Demenico ; Tonelli, Francesco ; Abbate, Rosanna</creator><creatorcontrib>Chiarantini, Elena ; Valanzano, Rosa ; Liotta, Agatina Alessandrello ; Cellai, Anna Paola ; Fedi, Sandra ; Ilari, Isabella ; Prisco, Demenico ; Tonelli, Francesco ; Abbate, Rosanna</creatorcontrib><description>Patients affected by inflammatory bowel disease (IBD) frequently suffer from thromboembolic events. Aims of this study were to investigate hemostatic system and the presence of antiphospholipid antibodies (aPL) in IBD patients. Forty-one patients affected by Crohn's disease (CD) and 19 by ulcerative colitis (UC) were studied, compared to 40 healthy control subjects. platelet count (PLT), PT, aPTT, fibrinogen (Fib), prothrombin fragment F1+2, antithrombin (AT), protein C (PC), protein S (PS), factor XIII (FXIII), plasminogen (PLG), plasminogen activator inhibitor (PAI), spontaneous platelet aggregation in platelet-rich plasma (PRP-SPA) and in whole blood (WB-SPA), and antiphospholipid antibodies (aPL) were evaluated. PLT, Fib, F1+2 and WB-SPA were significantly increased in IBD patients (p at least &lt;0.05) both in active and inactive phases; aPL positivity was more frequent (p&lt;0.05) and FXIII was significantly decreased (p&lt;0.05) in comparison to control subjects. The thrombophilic state of IBD patients is not related to the degree of activity of the disease or to previous thrombotic events; aPL express the immunological alterations connected with IBD and are not the main cause of thrombotic events.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(96)00060-6</identifier><identifier>PMID: 9163067</identifier><identifier>CODEN: THBRAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Antiphospholipid - blood ; Biological and medical sciences ; Blood Coagulation - immunology ; coagulation ; Colitis, Ulcerative - blood ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - immunology ; Crohn Disease - blood ; Crohn Disease - complications ; Crohn Disease - immunology ; Crohn's disease ; Female ; fibrinolysis ; Gastroenterology. Liver. Pancreas. Abdomen ; Hemostasis - physiology ; Humans ; inflammatory bowel disease ; Male ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Thrombosis - complications ; ulcerative colitis</subject><ispartof>Thrombosis research, 1996-04, Vol.82 (2), p.137-146</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-845bb621bfa03fd681224ed2caae73ff87f9886831545f20ae19f1400e70ed8d3</citedby><cites>FETCH-LOGICAL-c452t-845bb621bfa03fd681224ed2caae73ff87f9886831545f20ae19f1400e70ed8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0049-3848(96)00060-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3064924$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9163067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiarantini, Elena</creatorcontrib><creatorcontrib>Valanzano, Rosa</creatorcontrib><creatorcontrib>Liotta, Agatina Alessandrello</creatorcontrib><creatorcontrib>Cellai, Anna Paola</creatorcontrib><creatorcontrib>Fedi, Sandra</creatorcontrib><creatorcontrib>Ilari, Isabella</creatorcontrib><creatorcontrib>Prisco, Demenico</creatorcontrib><creatorcontrib>Tonelli, Francesco</creatorcontrib><creatorcontrib>Abbate, Rosanna</creatorcontrib><title>Hemostatic abnormalities in inflammatory bowel disease</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Patients affected by inflammatory bowel disease (IBD) frequently suffer from thromboembolic events. Aims of this study were to investigate hemostatic system and the presence of antiphospholipid antibodies (aPL) in IBD patients. Forty-one patients affected by Crohn's disease (CD) and 19 by ulcerative colitis (UC) were studied, compared to 40 healthy control subjects. platelet count (PLT), PT, aPTT, fibrinogen (Fib), prothrombin fragment F1+2, antithrombin (AT), protein C (PC), protein S (PS), factor XIII (FXIII), plasminogen (PLG), plasminogen activator inhibitor (PAI), spontaneous platelet aggregation in platelet-rich plasma (PRP-SPA) and in whole blood (WB-SPA), and antiphospholipid antibodies (aPL) were evaluated. PLT, Fib, F1+2 and WB-SPA were significantly increased in IBD patients (p at least &lt;0.05) both in active and inactive phases; aPL positivity was more frequent (p&lt;0.05) and FXIII was significantly decreased (p&lt;0.05) in comparison to control subjects. The thrombophilic state of IBD patients is not related to the degree of activity of the disease or to previous thrombotic events; aPL express the immunological alterations connected with IBD and are not the main cause of thrombotic events.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Antiphospholipid - blood</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation - immunology</subject><subject>coagulation</subject><subject>Colitis, Ulcerative - blood</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - immunology</subject><subject>Crohn Disease - blood</subject><subject>Crohn Disease - complications</subject><subject>Crohn Disease - immunology</subject><subject>Crohn's disease</subject><subject>Female</subject><subject>fibrinolysis</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hemostasis - physiology</subject><subject>Humans</subject><subject>inflammatory bowel disease</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Thrombosis - complications</subject><subject>ulcerative colitis</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo67r6DxR6ENFDdZKmaXIRZFFXWPCi55CmE4j0Y026yv57W7bsURgYhveZYXgIuaRwT4GKBwCu0kxyeavEHQAISMURmVNZqJTxgh2T-QE5JWcxfgHQgqp8RmaKigxEMSdihU0Xe9N7m5iy7UJjat97jIlvh3K1aRrTd2GXlN0v1knlI5qI5-TEmTrixdQX5PPl-WO5Stfvr2_Lp3Vqec76VPK8LAWjpTOQuUpIyhjHilljsMick4VTUgqZ0ZznjoFBqhzlAFgAVrLKFuRmf3cTuu8txl43Plqsa9Nit426kDyjMpMDyPegDV2MAZ3eBN-YsNMU9KhLjy706EKrcRh0aTGsXU33t2WD1WFp8jPk11NuojW1C6a1Ph6wgeGK8QF73GM4uPjxGHS0HluLlQ9oe111_v8__gBj94WR</recordid><startdate>19960415</startdate><enddate>19960415</enddate><creator>Chiarantini, Elena</creator><creator>Valanzano, Rosa</creator><creator>Liotta, Agatina Alessandrello</creator><creator>Cellai, Anna Paola</creator><creator>Fedi, Sandra</creator><creator>Ilari, Isabella</creator><creator>Prisco, Demenico</creator><creator>Tonelli, Francesco</creator><creator>Abbate, Rosanna</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960415</creationdate><title>Hemostatic abnormalities in inflammatory bowel disease</title><author>Chiarantini, Elena ; Valanzano, Rosa ; Liotta, Agatina Alessandrello ; Cellai, Anna Paola ; Fedi, Sandra ; Ilari, Isabella ; Prisco, Demenico ; Tonelli, Francesco ; Abbate, Rosanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-845bb621bfa03fd681224ed2caae73ff87f9886831545f20ae19f1400e70ed8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Antiphospholipid - blood</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation - immunology</topic><topic>coagulation</topic><topic>Colitis, Ulcerative - blood</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - immunology</topic><topic>Crohn Disease - blood</topic><topic>Crohn Disease - complications</topic><topic>Crohn Disease - immunology</topic><topic>Crohn's disease</topic><topic>Female</topic><topic>fibrinolysis</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hemostasis - physiology</topic><topic>Humans</topic><topic>inflammatory bowel disease</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Thrombosis - complications</topic><topic>ulcerative colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiarantini, Elena</creatorcontrib><creatorcontrib>Valanzano, Rosa</creatorcontrib><creatorcontrib>Liotta, Agatina Alessandrello</creatorcontrib><creatorcontrib>Cellai, Anna Paola</creatorcontrib><creatorcontrib>Fedi, Sandra</creatorcontrib><creatorcontrib>Ilari, Isabella</creatorcontrib><creatorcontrib>Prisco, Demenico</creatorcontrib><creatorcontrib>Tonelli, Francesco</creatorcontrib><creatorcontrib>Abbate, Rosanna</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiarantini, Elena</au><au>Valanzano, Rosa</au><au>Liotta, Agatina Alessandrello</au><au>Cellai, Anna Paola</au><au>Fedi, Sandra</au><au>Ilari, Isabella</au><au>Prisco, Demenico</au><au>Tonelli, Francesco</au><au>Abbate, Rosanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemostatic abnormalities in inflammatory bowel disease</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1996-04-15</date><risdate>1996</risdate><volume>82</volume><issue>2</issue><spage>137</spage><epage>146</epage><pages>137-146</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><coden>THBRAA</coden><abstract>Patients affected by inflammatory bowel disease (IBD) frequently suffer from thromboembolic events. Aims of this study were to investigate hemostatic system and the presence of antiphospholipid antibodies (aPL) in IBD patients. Forty-one patients affected by Crohn's disease (CD) and 19 by ulcerative colitis (UC) were studied, compared to 40 healthy control subjects. platelet count (PLT), PT, aPTT, fibrinogen (Fib), prothrombin fragment F1+2, antithrombin (AT), protein C (PC), protein S (PS), factor XIII (FXIII), plasminogen (PLG), plasminogen activator inhibitor (PAI), spontaneous platelet aggregation in platelet-rich plasma (PRP-SPA) and in whole blood (WB-SPA), and antiphospholipid antibodies (aPL) were evaluated. PLT, Fib, F1+2 and WB-SPA were significantly increased in IBD patients (p at least &lt;0.05) both in active and inactive phases; aPL positivity was more frequent (p&lt;0.05) and FXIII was significantly decreased (p&lt;0.05) in comparison to control subjects. The thrombophilic state of IBD patients is not related to the degree of activity of the disease or to previous thrombotic events; aPL express the immunological alterations connected with IBD and are not the main cause of thrombotic events.</abstract><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>9163067</pmid><doi>10.1016/0049-3848(96)00060-6</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 1996-04, Vol.82 (2), p.137-146
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_78431838
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Antiphospholipid - blood
Biological and medical sciences
Blood Coagulation - immunology
coagulation
Colitis, Ulcerative - blood
Colitis, Ulcerative - complications
Colitis, Ulcerative - immunology
Crohn Disease - blood
Crohn Disease - complications
Crohn Disease - immunology
Crohn's disease
Female
fibrinolysis
Gastroenterology. Liver. Pancreas. Abdomen
Hemostasis - physiology
Humans
inflammatory bowel disease
Male
Medical sciences
Middle Aged
Other diseases. Semiology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Thrombosis - complications
ulcerative colitis
title Hemostatic abnormalities in inflammatory bowel disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T22%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemostatic%20abnormalities%20in%20inflammatory%20bowel%20disease&rft.jtitle=Thrombosis%20research&rft.au=Chiarantini,%20Elena&rft.date=1996-04-15&rft.volume=82&rft.issue=2&rft.spage=137&rft.epage=146&rft.pages=137-146&rft.issn=0049-3848&rft.eissn=1879-2472&rft.coden=THBRAA&rft_id=info:doi/10.1016/0049-3848(96)00060-6&rft_dat=%3Cproquest_cross%3E78431838%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78431838&rft_id=info:pmid/9163067&rft_els_id=0049384896000606&rfr_iscdi=true